Imagen de Portada

A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Ling Xue, Guangda Ma, Nick Holford, Qiong Qin, Yinglong Ding, Jacqueline A. Hannam, Xiaoliang Ding, Hongyou Fan, Zhenchun Ji, Biwen Yang, Han Shen, Zhenya Shen, Liyan Miao
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Clinical Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Letter: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants
por: Jiaqi Shen, et al.
Publicado: (2026)

Clinical Trial: Immunogenicity of Double‐Dose Versus Standard‐Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel Disease
por: Anupam Kumar Singh, et al.
Publicado: (2025)

Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease
por: Nicholas Clark, et al.
Publicado: (2025)

Research Communication: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants
por: Lauren Holtslander, et al.
Publicado: (2025)

Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement
por: Abdelrahman Saqr, et al.
Publicado: (2025)

Model‐Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial
por: Jules M. Janssen Daalen, et al.
Publicado: (2024)

Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model
por: Miramar Sami Kardouh, et al.
Publicado: (2025)

Post hoc Population Standardization of Trial Emulation Studies in Claims Data: An RCT ‐ DUPLICATE Analysis
por: Phyo Than Htoo, et al.
Publicado: (2026)

Beyond Population‐Level Targets for Drug Concentrations: Precision Dosing Needs Individual‐Level Targets that Include Superior Biomarkers of Drug Responses
por: Thomas M. Polasek, et al.
Publicado: (2024)

Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis
por: Prateek Sharma, et al.
Publicado: (2025)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial
por: Yu Yang, et al.
Publicado: (2024)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply
por: Nauzer Forbes, et al.
Publicado: (2024)

Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial
por: Dave Singh, et al.
Publicado: (2025)

Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials
por: Mira G.P. Zuidgeest, et al.
Publicado: (2025)

Assessment of Dosing Strategies for Pediatric Drug Products
por: Zachary L. Taylor, et al.
Publicado: (2024)

Letter: Steroid Tapering—Is Shorter Duration Better?
por: Juntao Lu, et al.
Publicado: (2026)

Correction to “Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals”
Publicado: (2024)

Operationalizing Decentralized Clinical Trials: Technology Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial
por: Sten Hanke, et al.
Publicado: (2025)

Longitudinal Tumor Size and Survival Modeling for Exposure–Response Analysis of Drugs with Frequent Dose Reductions: Dose Justification of Abemaciclib in Patients with Metastatic Breast Cancer
por: Emmanuel Chigutsa, et al.
Publicado: (2026)

Moving the Needle for Oncology Dose Optimization: A Call for Action
por: Karthik Venkatakrishnan, et al.
Publicado: (2024)

Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future
por: Karen Rowland Yeo, et al.
Publicado: (2024)

Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study
por: Judith Y. M. N. Derijks‐Engwegen, et al.
Publicado: (2024)

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma
por: Ruben Malmberg, et al.
Publicado: (2025)

Letter: Ulcerative proctitis—A step towards addressing the knowledge gap, and a call for greater detail, in trial data
por: John David Chetwood, et al.
Publicado: (2024)

Model‐Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations
por: Rashudy F. Mahomedradja, et al.
Publicado: (2025)

Letter: Lubiprostone Treatment for MASLD—Gender Imbalance and Blinding Considerations
por: Jiru Li, et al.
Publicado: (2025)

Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
por: Peter N. Morcos, et al.
Publicado: (2024)

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
por: Mariam A. Ahmed, et al.
Publicado: (2024)

Editorial: UDCA Dosing in PBC – Between Guideline Adherence and Clinical Reality
por: Helena Hernández‐Évole, et al.
Publicado: (2026)

Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
por: Andrew B. SyBing, et al.
Publicado: (2025)

Infrequent Resolution of Vaso‐Occlusive Crises in Routine Clinical Care Among Patients Mimicking the Exa‐Cel Trial Population: A Cohort Study of Medicaid Enrollees
por: Mufaddal Mahesri, et al.
Publicado: (2024)

Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization
por: Helga Gardarsdottir, et al.
Publicado: (2025)

Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras
por: Daniel Tassone, et al.
Publicado: (2024)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
por: Mohamed Elmeliegy, et al.
Publicado: (2024)

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens
por: Sung‐Chun Tang, et al.
Publicado: (2025)

Crossing the Chasm: How to Approach Translational Pharmacokinetic–Pharmacodynamic Modeling of Phage Dosing
por: Gauri G. Rao, et al.
Publicado: (2024)

The Drug Titration Paradox Updated and Reinterpreted: With Perfect Titration, Dose and Effect Will Be Uncorrelated
por: Elie Sarraf, et al.
Publicado: (2025)

Pharmacokinetics and Exposure–Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease
por: Sumit Bhatnagar, et al.
Publicado: (2024)

A User‐Driven Framework for Dose Selection in Pregnancy: Proof of Concept for Sertraline
por: Charlotte Koldeweij, et al.
Publicado: (2024)

AI ‐Enabled Precision Dosing in Pediatrics: Enhancing Model‐Informed Decision Making
por: Kei Irie, et al.
Publicado: (2026)